![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 10
Zeitschriftenartikel
Maier, Sebastian H. 
ORCID: https://orcid.org/0000-0003-0120-8842; Schönecker, Stephan ORCID: https://orcid.org/0000-0003-0359-8960; Anagnostatou, Vasiliki ORCID: https://orcid.org/0009-0009-8438-2758; Garny, Sylvia; Nitschmann, Alexander ORCID: https://orcid.org/0009-0000-8620-2305; Fleischmann, Daniel F.; Büttner, Marcel; Kaul, David; Imhoff, Detlef ORCID: https://orcid.org/0000-0003-3627-7370; Fokas, Emmanouil; Seidel, Clemens ORCID: https://orcid.org/0000-0001-8178-5089; Hau, Peter; Kölbl, Oliver; Popp, Ilinca; Grosu, Anca-Ligia; Haussmann, Jan; Budach, Wilfried; Celik, Eren; Kahl, Klaus-Henning ORCID: https://orcid.org/0000-0002-0545-1367; Hoffmann, Elgin ORCID: https://orcid.org/0000-0002-9214-919X; Tabatabai, Ghazaleh; Paulsen, Frank; Holzgreve, Adrien ORCID: https://orcid.org/0000-0002-9566-8438; Albert, Nathalie L.; Mansmann, Ulrich ORCID: https://orcid.org/0000-0002-9955-8906; Corradini, Stefanie; Belka, Claus; Niyazi, Maximilian und Bodensohn, Raphael ORCID: https://orcid.org/0000-0002-1114-2771
(2024):
Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06).
In: Clinical and Translational Radiation Oncology, Bd. 47, 100790
[PDF, 10MB]
ORCID: https://orcid.org/0000-0003-0120-8842; Schönecker, Stephan ORCID: https://orcid.org/0000-0003-0359-8960; Anagnostatou, Vasiliki ORCID: https://orcid.org/0009-0009-8438-2758; Garny, Sylvia; Nitschmann, Alexander ORCID: https://orcid.org/0009-0000-8620-2305; Fleischmann, Daniel F.; Büttner, Marcel; Kaul, David; Imhoff, Detlef ORCID: https://orcid.org/0000-0003-3627-7370; Fokas, Emmanouil; Seidel, Clemens ORCID: https://orcid.org/0000-0001-8178-5089; Hau, Peter; Kölbl, Oliver; Popp, Ilinca; Grosu, Anca-Ligia; Haussmann, Jan; Budach, Wilfried; Celik, Eren; Kahl, Klaus-Henning ORCID: https://orcid.org/0000-0002-0545-1367; Hoffmann, Elgin ORCID: https://orcid.org/0000-0002-9214-919X; Tabatabai, Ghazaleh; Paulsen, Frank; Holzgreve, Adrien ORCID: https://orcid.org/0000-0002-9566-8438; Albert, Nathalie L.; Mansmann, Ulrich ORCID: https://orcid.org/0000-0002-9955-8906; Corradini, Stefanie; Belka, Claus; Niyazi, Maximilian und Bodensohn, Raphael ORCID: https://orcid.org/0000-0002-1114-2771
(2024):
Dummy run for planning of isotoxic dose-escalated radiation therapy for glioblastoma used in the PRIDE trial (NOA-28; ARO-2024-01; AG-NRO-06).
In: Clinical and Translational Radiation Oncology, Bd. 47, 100790
[PDF, 10MB]
Zeyen, Thomas; Potthoff, Anna-Laura; Nemeth, Robert; Heiland, Dieter H.; Burger, Michael C.; Steinbach, Joachim P.; Hau, Peter; Tabatabai, Ghazaleh; Glas, Martin; Schlegel, Uwe; Grauer, Oliver; Krex, Dietmar; Schnell, Oliver; Goldbrunner, Roland; Sabel, Michael; Thon, Niklas; Delev, Daniel; Clusmann, Hans; Seidel, Clemens; Gueresir, Erdem; Schmid, Matthias; Schuss, Patrick; Giordano, Frank A.; Radbruch, Alexander; Becker, Albert; Weller, Johannes; Schaub, Christina; Vatter, Hartmut; Schilling, Judith; Winkler, Frank; Herrlinger, Ulrich und Schneider, Matthias
(2022):
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial.
In: Trials, Bd. 23, Nr. 1, 57
Krug, David; Hecht, Markus; Ebert, Nadja; Mäurer, Matthias; Fleischmann, Daniel F.; Fokas, Emmanouil; Straube, Christoph; Nicolay, Nils Henrik; Hörner-Rieber, Juliane; Schmitt, Daniela; von Neubeck, Cläre; Zamboglou, Constantinos; Sperk, Elena; Kaul, David; Hess, Julia; Corradini, Stefanie; Seidel, Clemens; Gani, Cihan; Baues, Christian; Frey, Benjamin; Blanck, Oliver; Gauer, Tobias und Niyazi, Maximilian
(2021):
Innovative radiation oncology Together - Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in Germany.
In: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... et al, Bd. 197, Nr. 12: S. 1043-1048
[PDF, 776kB]
Dietzsch, Stefan; Braesigk, Annett; Seidel, Clemens; Remmele, Julia; Kitzing, Ralf; Schlender, Tina; Mynarek, Martin; Geismar, Dirk; Jablonska, Karolina; Schwarz, Rudolf; Pazos, Montserrat; Weber, Damien C.; Frick, Silke; Gurtner, Kristin; Matuschek, Christiane; Harrabi, Semi Ben; Gluck, Albrecht; Lewitzki, Victor; Dieckmann, Karin; Benesch, Martin; Gerber, Nicolas U.; Obrecht, Denise; Rutkowski, Stefan; Timmermann, Beate und Kortmann, Rolf-Dieter
(2021):
Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma-an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial.
In: Strahlentherapie und Onkologie, Bd. 198, Nr. 3: S. 282-290
Krug, David; Hecht, Markus; Ebert, Nadja; Maeurer, Matthias; Fleischmann, Daniel F.; Fokas, Emmanouil; Straube, Christoph; Nicolay, Nils Henrik; Hoerner-Rieber, Juliane; Schmitt, Daniela; Neubeck, Clare von; Zamboglou, Constantinos; Sperk, Elena; Kaul, David; Hess-Rieger, Julia; Corradini, Stefanie; Seidel, Clemens; Gani, Cihan; Baues, Christian; Frey, Benjamin; Blanck, Oliver; Gauer, Tobias und Niyazi, Maximilian
(2021):
Innovative radiation oncology Together - Precise, Personalized, Human Vision 2030 for radiotherapy & radiation oncology in Germany.
In: Strahlentherapie und Onkologie, Bd. 197, Nr. 12: S. 1043-1048
Tzaridis, Theophilos; Schaefer, Niklas; Weller, Johannes; Steinbach, Joachim-Peter; Schlegel, Uwe; Seidel, Sabine; Sabel, Michael; Hau, Peter; Seidel, Clemens; Krex, Dietmar; Goldbrunner, Roland; Tonn, Jörg-Christian; Grauer, Oliver; Kebir, Sied; Schneider, Matthias; Schaub, Christina; Vatter, Hartmut; Coch, Christoph; Glas, Martin; Fimmers, Rolf; Pietsch, Torsten; Reifenberger, Guido; Herrlinger, Ulrich und Felsberg, Jörg
(2020):
MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial.
In: International Journal of Cancer, Bd. 148, Nr. 7: S. 1695-1707
Dietzsch, Stefan; Braesigk, Annett; Seidel, Clemens; Remmele, Julia; Kitzing, Ralf; Schlender, Tina; Mynarek, Martin; Geismar, Dirk; Jablonska, Karolina; Schwarz, Rudolf; Pazos, Montserrat; Walser, Marc; Frick, Silke; Gurtner, Kristin; Matuschek, Christiane; Ben Harrabi, Semi; Gluek, Albrecht; Lewitzki, Victor; Dieckmann, Karin; Benesch, Martin; Gerber, Nicolas U.; Rutkowski, Stefan; Timmermann, Beate und Kortmann, Rolf-Dieter
(2020):
Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial.
In: Strahlentherapie und Onkologie, Bd. 197, Nr. 8: S. 674-682
Matuschek, Christiane; Nestle-Kraemling, Carolin; Kuehn, Thorsten; Fehm, Tanja; Boelke, Edwin; Corradini, Stefanie; Fastner, Gerd; Maas, Kitti; Seidel, Clemens und Budach, Wilfried
(2020):
Neoadjuvant Radio(chemo)therapy for Breast Cancer: An Old Concept Revisited.
In: Breast Care, Bd. 15, Nr. 2: S. 112-117
Kebir, Sied; Schaub, Christina; Junold, Nina; Hattingen, Elke; Schäfer, Niklas; Steinbach, Joachim P.; Weyerbrock, Astrid; Hau, Peter; Goldbrunner, Roland; Galldiks, Norbert; Weller, Johannes; Mack, Frederic; Tzaridis, Theophilos; Baehr, Oliver; Seidel, Clemens; Schlegel, Uwe; Schmidt-Graf, Friederike; Rohde, Veit; Borchers, Christian; Tabatabai, Ghazaleh; Haenel, Mathias; Sabel, Michael; Gerlach, Rüdiger; Krex, Dietmar; Belka, Claus; Vatter, Hartmut; Proescholdt, Martin; Glas, Martin und Herrlinger, Ulrich
(2019):
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
In: Journal of Neuro-Oncology, Bd. 144, Nr. 3: S. 501-509
Herrlinger, Ulrich; Tzaridis, Theophilos; Mack, Frederic; Steinbach, Joachim Peter; Schlegel, Uwe; Sabel, Michael; Hau, Peter; Kortmann, Rolf-Dieter; Krex, Dietmar; Grauer, Oliver; Goldbrunner, Roland; Schnell, Oliver; Baehr, Oliver; Uhl, Martin; Seidel, Clemens; Tabatabai, Ghazaleh; Kowalski, Thomas; Ringel, Florian; Schmidt-Graf, Friederike; Suchorska, Bogdana; Brehmer, Stefanie; Weyerbrock, Astrid; Renovanz, Miriam; Bullinger, Lars; Galldiks, Norbert; Vajkoczy, Peter; Misch, Martin; Vatter, Hartmut; Stuplich, Moritz; Schäfer, Niklas; Kebir, Sied; Weller, Johannes; Schaub, Christina; Stummer, Walter; Tonn, Jörg-Christian; Simon, Matthias; Keil, Vera C.; Nelles, Michael; Urbach, Horst; Coenen, Martin; Wick, Wolfgang; Weller, Michael; Fimmers, Rolf; Schmid, Matthias; Hattingen, Elke; Pietsch, Torsten; Coch, Christoph und Glas, Martin
(2019):
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
In: Lancet, Bd. 393, Nr. 10172: S. 678-688